Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 21, 1997 - Issue 6
33
Views
4
CrossRef citations to date
0
Altmetric
Miscellaneous Article

HB Siirt [β27(β9)ALA→GLY]: A New, Electrophoretically Silent, Hemoglobin Variant

, , , &
Pages 495-497 | Received 17 Mar 1997, Accepted 14 Aug 1997, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maria Pia Cappabianca, Alessia Colosimo, Annalaura Sabatucci, Enrico Dainese, Paola Di Biagio, Roberta Piscitelli, Ofelia Sarra, Daniela Zei & Antonio Amato. (2017) A Clinical Update of the Hb Siirt [β27(B9)Ala→Gly; HBB: c.83C>G] Hemoglobin Variant. Hemoglobin 41:1, pages 53-55.
Read now

Articles from other publishers (3)

Taher Mahmoud, Chaima Sahli, Sondess Hadj Fredj, Yessine Amri, Rim Othmani, Ghaber S. Mohamed, Ekhtelbenina Zein & Taieb Messaoud. (2022) Epidemiological and molecular study of hemoglobinopathies in Mauritanian patients. Molecular Genetics & Genomic Medicine 10:10.
Crossref
Angela N. Barrett, Ramasamy Saminathan & Mahesh Choolani. (2017) Thalassaemia screening and confirmation of carriers in parents. Best Practice & Research Clinical Obstetrics & Gynaecology 39, pages 27-40.
Crossref
D.J. Weatherall & J.B. Clegg. 2001. The Thalassaemia Syndromes. The Thalassaemia Syndromes 733 821 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.